Pharmaceutical

Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Atopic Dermatitis

Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial  KT-621 BROADEN2...

BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025

Veritiv Expands Its TempSafe® Portfolio With the Industry’s First Curbside-Recyclable Pallet Shipper for Biopharmaceutical Cold Chain

ATLANTA, Dec. 10, 2025 /PRNewswire/ -- Veritiv Operating Company, a leader in specialty packaging distribution, facility solutions and print products and...

Sant’ Andrea University Hospital to Integrate GE HealthCare and Tribun Health’s Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care

GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire /...

Sant’ Andrea University Hospital to Integrate GE HealthCare and Tribun Health’s Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care

GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire /...

error: Content is protected !!